A Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid Leukemia
Clinical trial NCT02826642 · WITHDRAWN
Trial details
- NCT number
- NCT02826642
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-26
- Primary completion
- 2016-11-29
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.